Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: Jeffrey L. Henken who wrote (396)	4/1/1998 3:42:00 AM
From: Russel W. Kennel	Read Replies (2) \| Respond to of 2887

Any speculation on future revenues/earnings based on recent developments? With 17+ mil shares out, up from 11 mil, a ten fold increase would only be $6 mil revenue. As a comparison, I recently invested in a $.43 penny stock with a $.31 per share annual net, on $5 Mil revenues, and $4.00 per share book value. Looks to me that if $.61 price is a steal, there is a lot riding on a $100 mil takeover to bring the value up into the $5 range. Or, alternatively, there is a huge bet that revenues will increase 10 to 20 fold (or more) soon. I wonder which scenario has the biggest chance and when? In other words, you invest in a penny stock on the bet that it is very inefficiently priced. Any takers? Russ